Antimicrobial copper-alloy touch surfaces follows: The following claims are now legally permitted when marketing EPA-registered antimicrobial copper alloys in the U.S.: The registrations state that “antimicrobial copper alloys may be used in hospitals, other healthcare facilities, and various public, commercial and residential buildings.” The EPA copper alloy registrations were granted “with public health claims,” meaning that they permit manufacturers of copper-based products sold in the U.S. to claim on their labels the ability of copper, brass, and bronze to kill harmful, potentially deadly bacteria. As a condition of registration established by EPA, the Copper Development Association (CDA) in the U.S. is responsible for the
Antimicrobial copper-alloy touch surfaces University Hospital in Manhasset, New York. An alloy of 90% Cu 10% Ni significantly lowered the microbial burden, primarily "Staphylococci", on arm surfaces of phlebotomy chairs versus wooden arm surfaces. The median reduction for total bacteria on the copper alloy chairs arms was 90%. Use of the chair with copper arm tops resulted in a 17-fold lower risk of exposure to environmental microbes than when patients used the standard chair. The majority of the samples from the chairs with copper components were below the 500 CFU/cm level believed to represent a risk to hospital patients. The microbiocidal properties of the